iHuman Free Cash Flow (FCF) History (IH)

iHuman reported ¥46.4M in free cash flow for fiscal 2025, a decrease of 9.17% from the previous fiscal year, with a free cash flow margin of 5.75%.

View full iHuman company overview

iHuman free cash flow by year

iHuman annual free cash flow

Fiscal yearPeriod endedFree cash flowChangeGrowthFCF margin
20252025-12-31¥46.4M−¥4.7M−9.17%+5.75%
20242024-12-31¥51.1M−¥114.5M−69.15%+5.54%
20232023-12-31¥165.6M−¥16.3M−8.94%+16.27%
20222022-12-31¥181.9M¥175.9M+2966.57%+18.46%
20212021-12-31¥5.9M−¥201.1M−97.14%+0.63%
20202020-12-31¥207.1M¥166.8M+414.66%+38.93%
20192019-12-31¥40.2M¥45.3M+18.40%
20182018-12-31−¥5.0M−3.82%

iHuman free cash flow growth trends

Over the last five reported fiscal years, free cash flow declined from ¥207.1M to ¥46.4M, a compound annual decline of 25.85%.

About the metric

What free cash flow means

Free cash flow is the cash a company generates from operations after capital expenditures. Positive FCF can fund dividends, buybacks, debt repayment, or reinvestment; negative FCF means capital spending exceeded operating cash flow for that period.

Calculation and source

How free cash flow is calculated

TickerStat calculates free cash flow as SEC-reported operating cash flow minus capital expenditures. FCF margin equals free cash flow divided by revenue. Fiscal periods can differ from calendar years, so the tables include exact period-end dates.

Review iHuman filings at SEC.gov ↗